EverSource Wealth Advisors LLC raised its stake in shares of Equifax Inc. (NYSE:EFX – Free Report) by 34.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,515 shares of the credit services provider’s stock after purchasing an additional 646 shares during the period. EverSource Wealth Advisors LLC’s holdings in Equifax were worth $641,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in EFX. Assetmark Inc. grew its holdings in Equifax by 8.7% during the third quarter. Assetmark Inc. now owns 6,588 shares of the credit services provider’s stock valued at $1,936,000 after purchasing an additional 527 shares during the last quarter. Ashton Thomas Securities LLC bought a new stake in shares of Equifax in the third quarter valued at approximately $29,000. Versor Investments LP bought a new stake in shares of Equifax in the third quarter valued at approximately $264,000. Apollon Wealth Management LLC boosted its position in shares of Equifax by 18.8% in the third quarter. Apollon Wealth Management LLC now owns 2,242 shares of the credit services provider’s stock valued at $659,000 after acquiring an additional 355 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. boosted its position in shares of Equifax by 0.5% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 273,033 shares of the credit services provider’s stock valued at $80,233,000 after acquiring an additional 1,461 shares during the period. Institutional investors and hedge funds own 96.20% of the company’s stock.
Equifax Stock Down 0.9 %
Shares of NYSE EFX opened at $237.14 on Friday. The stock has a market cap of $29.41 billion, a PE ratio of 49.10, a PEG ratio of 2.79 and a beta of 1.65. The business has a fifty day moving average of $254.17 and a two-hundred day moving average of $268.68. Equifax Inc. has a 52-week low of $213.02 and a 52-week high of $309.63. The company has a debt-to-equity ratio of 0.90, a quick ratio of 0.88 and a current ratio of 0.75.
Equifax Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Friday, February 21st will be issued a $0.39 dividend. The ex-dividend date is Friday, February 21st. This represents a $1.56 dividend on an annualized basis and a dividend yield of 0.66%. Equifax’s dividend payout ratio is 32.30%.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on the company. Barclays reduced their price objective on Equifax from $335.00 to $325.00 and set an “overweight” rating for the company in a research report on Friday, February 7th. Gordon Haskett raised Equifax to a “strong-buy” rating in a research report on Tuesday, February 18th. BNP Paribas raised Equifax from a “neutral” rating to an “outperform” rating and set a $305.00 price objective for the company in a research report on Monday, December 16th. Oppenheimer reduced their price objective on Equifax from $286.00 to $279.00 and set an “outperform” rating for the company in a research report on Friday, February 7th. Finally, UBS Group reduced their target price on Equifax from $335.00 to $310.00 and set a “buy” rating for the company in a research report on Friday, February 7th. Three investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Equifax has a consensus rating of “Moderate Buy” and a consensus price target of $301.13.
Get Our Latest Research Report on EFX
Equifax Company Profile
Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.
Further Reading
- Five stocks we like better than Equifax
- How to Use the MarketBeat Dividend Calculator
- 3 Undervalued Stocks You Can Buy at a Discount Now
- How to Short Nasdaq: An Easy-to-Follow Guide
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- What Is WallStreetBets and What Stocks Are They Targeting?
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Want to see what other hedge funds are holding EFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Equifax Inc. (NYSE:EFX – Free Report).
Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.